Expanded recall for Franck's Compounds

Share this article:

The FDA is notifying all physicians and healthcare organizations of the recall of all sterile products sold by Franck's Compounding Pharmacy since November 2011 due to the possibility of lack of sterility.

In March 19, 2012, FDA received reports of fungal endophthalmitis in patients who were given Brilliant Blue G (BBG), supplied by Franck's Pharmacy, during eye surgeries. In April 20, 2012, FDA received reports of eye infections in patients who were given injections of Franck's drug products containing triamcinolone acetonide during eye surgery.

An active investigation by the CDC and FDA is ongoing at this time. FDA advises that any product received from Franck's since November 2011 not be used.

For more information visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305592.htm.

Share this article:
You must be a registered member of Clinical Advisor to post a comment.

More in Web Exclusives

Twice-yearly PCP visits yield improved hypertension control

Twice-yearly PCP visits yield improved hypertension control

Health insurance and being treated for high cholesterol improved chances of keeping hypertension under control.

Do providers focus too much on symptoms?

Do providers focus too much on symptoms?

Disease-focused model of care may be inadequate for symptom-prompted outpatient visits.

Medication errors occur every 8 minutes in kids

Medication errors occur every 8 minutes in kids

Though 94% of those mistakes didn't require medical treatment, 25 led to deaths and about 1,900 critical care admissions.